Search for: "Pfizer Inc." Results 261 - 280 of 1,370
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Mar 2016, 4:00 am by Alan Macek
Pfizer Inc. et al., 2016 FC 136, that there was no legal basis to invalidate an issued patent due to non-patent of an administrative fee while the application was pending. [read post]
3 Mar 2016, 5:19 am
Pfizer, Inc., 153 S.W.3d 758, 766 (Ky. 2004) (DTC exception “recognized only by New Jersey”); Mendez Montes De Oca v. [read post]
19 Feb 2016, 1:30 pm by Tom Lamb
As for what little has happened since then concerning this proposed Viagra MDL case, we turn to this January 4, 2016 news report, "JPMDL Won’t Expedite Hearing On Viagra Skin Cancer MDL Motion": The Judicial Panel on Multidistrict Litigation (JPMDL) on Dec. 29 denied a joint request by Pfizer Inc. and Viagra plaintiffs to place a motion for a skin cancer multidistrict litigation on the panel’s Jan. 28 agenda (In Re: Viagra Products Liability Litigation, MDL… [read post]
14 Feb 2016, 9:00 am
., Board Certified by The Florida Bar in Health Law Two whistleblowers brought suit against Pfizer’s Wyeth Pharmaceutical Inc. [read post]
3 Feb 2016, 4:00 am by Alan Macek
Wyeth and Pfizer Canada Inc., 2011 FC 1169 at 34 reversed on other grounds 2012 FCA 141, Louis Vuitton Malletier S.A. v. [read post]
28 Jan 2016, 9:02 am by Gene Pierson
Patent Term Adjustment (PTA) is utilized by the Patent Office so that an inventor’s patent protection is not limited by delays caused by the Patent Office. [read post]
28 Jan 2016, 6:03 am
In October 2015, press reports began appearing suggesting that Pfizer Inc., one of the world’s largest pharmaceutical companies, and Allergan, an Irish publicly traded pharmaceutical company, were considering entering into the largest inversion in history. [read post]
21 Dec 2015, 3:00 am by Paul Caron
Marian (UC-Irvine), Inversions and Competitiveness: Reflections in the Wake of Pfizer/Allergan: The recent announcement that Pfizer Inc. has reached a merger agreement with Allergan PLC , with the combined entity being tax-resident in Ireland, is a good occasion to reconsider U.S. policy options... [read post]
13 Dec 2015, 4:01 pm
**********PREVIOUSLY, ON NEVER TOO LATENever too late 75 [week ending on Sunday 6 December] –  BHG on blocking injunctions | IP in Universities | Sweden on blocking injunctions | Canadian musings on patents | US Senate and trade secret reform | Chinese IP Courts | G1/14 referral and Article 108 EPC | PACE procedure (Procedure for Accelerated Conduct of Examination) ant the EPO | Greekat and trade mark partenalism | EPO Boards of Appeal tell AC: we were… [read post]
7 Dec 2015, 12:56 pm
**********PREVIOUSLY, ON NEVER TOO LATENever Too Late 74 [week ending on Sunday 29 November] –  Bob Marley copyright | Nintendo TPM triumphs in Italy | GIs and TMs in the EU | Prebalin again | YouTube will defend fair use | End-of-year reading |Stretchline Intellectual Properties Ltd v H&M Hennes & Mauritz UK Ltd | Goodbye from Jeremy, and thank you from us | Greekat on plain packaging | Rovi Guides Inc v Virgin Media Ltd &… [read post]
2 Dec 2015, 2:13 pm by Robert B. Milligan and Amy Abeloff
Besides the supporters appearing at the hearing today, the bill is also supported by a robust industry coalition that includes Adobe, AdvaMed, the Alliance of Automobile Manufacturers, the Association of Global Automakers, Inc., Biotechnology Industry Organization (BIO), The Boeing Company, Boston Scientific, BSA | The Software Alliance (BSA), Caterpillar Inc., Corning Incorporated, Eli Lilly and Company, General Electric, Honda, IBM, Illinois Tool Works Inc., Intel, The… [read post]